Fri, May 3, 2024

Larry Biegelsen Maintained (TNDM) at Buy with Increased Target to $50 on, May 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-50-on-may-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Larry Biegelsen of Wells Fargo, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Increased Target from $45 to $50 on, May 3rd, 2024.

Larry has made no other calls on TNDM in the last 4 months.



There are 3 other peers that have a rating on TNDM. Out of the 3 peers that are also analyzing TNDM, 2 agree with Larry's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $38 on, Wednesday, April 3rd, 2024
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024


This is the rating of the analyst that currently disagrees with Larry


  • Mike Kratky of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $45 on, Thursday, April 25th, 2024

Publication Contributing Sources